POBIS TNC CO., Ltd completed the acquisition of an additional 15.05% stake in NK Mulsan CO., LTD. from INNO Technology Fund 3, Optimus Investment Fund 2, Hyeyoung Na, River Stone Co., Ltd. and Medox Co., Ltd. for KRW 10.4 billion.
September 18, 2019
Share
POBIS TNC CO., Ltd (KOSDAQ:A016670) agreed to acquire an additional 17.45% stake in NK Mulsan CO., LTD. (KOSE:A009810) from INNO Technology Fund 3, Optimus Investment Fund 2, Hyeyoung Na, River Stone Co., Ltd. and Medox Co., Ltd. for KRW 12.1 billion on September 9, 2019. POBIS TNC will acquire 14.6 million shares. The consideration includes KRW 1 billion as deposit, KRW 5.7 billion to be paid until September 17, 2019 by INNO Technology Fund 3, Optimus Investment Fund 2 and Hyeyoung Na and KRW 5.3 billion to be paid until September 20, 2019 by River Stone Co., Ltd. and Medox Co., Ltd. The Board of POBIS TNC resolved the transaction on September 9, 2019. Samdo Accounting Corporation acted as the External Evaluation Body.
POBIS TNC CO., Ltd (KOSDAQ:A016670) completed the acquisition of an additional 15.05% stake in NK Mulsan CO., LTD. (KOSE:A009810) from INNO Technology Fund 3, Optimus Investment Fund 2, Hyeyoung Na, River Stone Co., Ltd. and Medox Co., Ltd. for KRW 10.4 billion on September 9, 2019. POBIS TNC acquired 12.6 million shares.
PlayGram Co Ltd formerly NK Mulsan Co Ltd is a Korea-based company principally engaged in the provision of corporate integrated purchasing agency services. The Company operates its business through two segments. The Maintenance Repair Operations (MRO) segment is engaged in the supply of subsidiary materials, maintenance materials, packaging and logistics materials, as well as research materials for business site operation. The Video Content Business segment is engaged in the planning, production and distribution of broadcast programs and performances.
POBIS TNC CO., Ltd completed the acquisition of an additional 15.05% stake in NK Mulsan CO., LTD. from INNO Technology Fund 3, Optimus Investment Fund 2, Hyeyoung Na, River Stone Co., Ltd. and Medox Co., Ltd. for KRW 10.4 billion.
PLAYGRAM CO., LTD. 